Targeted exome sequencing in anti-factor H antibody negative HUS reveals multiple variations

RW Thergaonkar, A Narang, BS Gurjar, P Tiwari… - Clinical and …, 2018 - Springer
Background Genetic susceptibility to atypical hemolytic uremic syndrome (aHUS) may lie
within genes regulating or activating the alternate complement and related pathways …
被引用次数：14 相关文章

Targeted exome sequencing in anti-factor H antibody negative HUS reveals multiple variations.

RW Thergaonkar, A Narang, BS Gurjar… - Clinical and …, 2017 - europepmc.org
Background Genetic susceptibility to atypical hemolytic uremic syndrome (aHUS) may lie
within genes regulating or activating the alternate complement and related pathways …

Targeted exome sequencing in anti-factor H antibody negative HUS reveals multiple variations.

RW Thergaonkar, A Narang, BS Gurjar… - Clinical & …, 2018 - search.ebscohost.com
Background: Genetic susceptibility to atypical hemolytic uremic syndrome (aHUS) may lie
within genes regulating or activating the alternate complement and related pathways …

Targeted exome sequencing in anti-factor H antibody negative HUS reveals multiple variations

RW Thergaonkar, A Narang… - Clinical and …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Genetic susceptibility to atypical hemolytic uremic syndrome (aHUS) may lie
within genes regulating or activating the alternate complement and related pathways …
[PDF] academia.edu

[PDF][PDF] Targeted exome sequencing in anti-factor H antibody negative HUS reveals multiple variations

RW Thergaonkar, A Narang, BS Gurjar, P Tiwari… - 2017 - academia.edu
Background Genetic susceptibility to atypical hemolytic uremic syndrome (aHUS) may lie
within genes regulating or activating the alternate complement and related pathways …

Targeted exome sequencing in anti-factor H antibody negative HUS reveals multiple variations

RW Thergaonkar, A Narang, BS Gurjar… - Clinical and …, 2018 - search.proquest.com
Background Genetic susceptibility to atypical hemolytic uremic syndrome (aHUS) may lie
within genes regulating or activating the alternate complement and related pathways …